SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (167)3/18/1998 10:35:00 PM
From: scaram(o)uche   of 337
 
Richard:

Stevens et al. used the magic word.... pharmacogenomics. VGI is going to bust their butts to make Clinical Partners look good to Roche, Glaxo, Gilead, Agouron, Merck, etc., etc., and Clinical Partners has to be hoping that the VGI relationship will cement and expand their relationships with insurance companies.

I don't look at the revenues that might accrue from this, and I really doubt that they are significant. To me, this is a route to patients and to getting virtually all decision-makers on the same page. Damn smart of Stevens et al. Absolutely brilliant of CP's management. I'll look forward to hearing that the Letter of Understanding has transformed into a firm deal.

Of interest..... systemsplus.com

From the release..... "The agreement .... commits the two companies to jointly develop HIV
managed care initiatives through payor networks based on VGI's HIV
genotyping system."

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News